MARKET

LXRX

LXRX

Lexicon Pharmaceuticals Inc
NASDAQ
0.6688
-0.0192
-2.79%
Pre Market: 0.6688 0 0.00% 04:20 04/30 EDT
OPEN
0.6999
PREV CLOSE
0.6880
HIGH
0.7000
LOW
0.6550
VOLUME
3.40K
TURNOVER
--
52 WEEK HIGH
2.450
52 WEEK LOW
0.2836
MARKET CAP
242.89M
P/E (TTM)
-1.0680
1D
5D
1M
3M
1Y
5Y
1D
Growth Is Priced Out Of Novo Nordisk
Seeking Alpha · 15h ago
Largest borrow rate increases among liquid names
TipRanks · 21h ago
Weekly Report: what happened at LXRX last week (0421-0425)?
Weekly Report · 2d ago
Top 2 Health Care Stocks That May Crash This Month
Benzinga · 4d ago
Weekly Report: what happened at LXRX last week (0414-0418)?
Weekly Report · 04/21 09:23
Weekly Report: what happened at LXRX last week (0407-0411)?
Weekly Report · 04/14 09:21
Largest borrow rate increases among liquid names
TipRanks · 04/10 12:45
Largest borrow rate increases among liquid names
TipRanks · 04/08 12:45
More
About LXRX
More
Lexicon Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. The Company pipeline includes INPEFA (sotagliflozin), LX9211, and LX9851. Sotagliflozin is an orally delivered small molecule compound that is being developed for the treatment of heart failure and type I diabetes, and type II diabetes mellitus, chronic kidney disease and other cardiovascular risk factors. LX9211 is an orally delivered small molecule compound that is being developed for the treatment of neuropathic pain. The Company is conducting a Phase II clinical trial of LX9211 in diabetic peripheral neuropathic pain and a second Phase II clinical trial of LX9211 in post-herpetic neuralgia. The Company is conducting preclinical development of LX9851, an orally delivered small molecule drug candidate, as a treatment for obesity and tool for weight management.
Recently
Symbol
Price
%Change

Webull offers Lexicon Pharmaceuticals Inc stock information, including NASDAQ: LXRX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LXRX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LXRX stock methods without spending real money on the virtual paper trading platform.